A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

An analysis of global pharmacovigilance data links higher-dose aflibercept to increased ocular adverse events vs aflibercept 2 mg and faricimab.

A series of 30 enucleated eyes, all of which had a primary histological diagnosis of scleritis, was analysed. The average age of patients at enucleation was 68 years; many of these patients had had ...